Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 222

1.

Early Rapid Decline in Kidney Function in Medically Managed Patients With Atherosclerotic Renal Artery Stenosis.

Cooper EL, Xie Y, Nguyen H, Brewster PS, Sholl H, Sharrett M, Ren K, Chen T, Tuttle KR, Haller ST, Jamerson K, Murphy TP, D'Agostino RB Sr, Massaro JM, Henrich W, Cooper CJ, Cutlip DE, Dworkin LD, Shapiro JI.

J Am Heart Assoc. 2019 Jun 4;8(11):e012366. doi: 10.1161/JAHA.119.012366. Epub 2019 Jun 1.

PMID:
31433717
2.

Metabolic Syndrome and Salt-Sensitive Hypertension in Polygenic Obese TALLYHO/JngJ Mice: Role of Na/K-ATPase Signaling.

Yan Y, Wang J, Chaudhry MA, Nie Y, Sun S, Carmon J, Shah PT, Bai F, Pratt R, Brickman C, Sodhi K, Kim JH, Pierre S, Malhotra D, Rankin GO, Xie ZJ, Shapiro JI, Liu J.

Int J Mol Sci. 2019 Jul 16;20(14). pii: E3495. doi: 10.3390/ijms20143495.

3.

Beneficial Role of HO-1-SIRT1 Axis in Attenuating Angiotensin II-Induced Adipocyte Dysfunction.

Lakhani HV, Zehra M, Pillai SS, Puri N, Shapiro JI, Abraham NG, Sodhi K.

Int J Mol Sci. 2019 Jun 29;20(13). pii: E3205. doi: 10.3390/ijms20133205.

4.

Information within residency monthly evaluation forms at two institutions.

Cooper CJ, Wehner P, Dailey C, O'Connor N, Kleshinski J, Shapiro JI.

Med Educ Online. 2019 Dec;24(1):1635844. doi: 10.1080/10872981.2019.1635844.

5.

The Adipocyte Na/K-ATPase Oxidant Amplification Loop is the Central Regulator of Western Diet-Induced Obesity and Associated Comorbidities.

Pratt RD, Brickman C, Nawab A, Cottrill C, Snoad B, Lakhani HV, Jelcick A, Henderson B, Bhardwaj NN, Sanabria JR, Liu J, Xie Z, Abraham NG, Shapiro JI, Sodhi K.

Sci Rep. 2019 May 28;9(1):7927. doi: 10.1038/s41598-019-44350-9.

6.

Prediction of cardiovascular outcomes with machine learning techniques: application to the Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL) study.

Chen T, Brewster P, Tuttle KR, Dworkin LD, Henrich W, Greco BA, Steffes M, Tobe S, Jamerson K, Pencina K, Massaro JM, D'Agostino RB Sr, Cutlip DE, Murphy TP, Cooper CJ, Shapiro JI.

Int J Nephrol Renovasc Dis. 2019 Mar 21;12:49-58. doi: 10.2147/IJNRD.S194727. eCollection 2019.

7.

Evolving concepts in the pathogenesis of uraemic cardiomyopathy.

Wang X, Shapiro JI.

Nat Rev Nephrol. 2019 Mar;15(3):159-175. doi: 10.1038/s41581-018-0101-8. Review.

PMID:
30664681
8.

Phenotypic Alteration of Hepatocytes in Non-Alcoholic Fatty Liver Disease.

Lakhani HV, Sharma D, Dodrill MW, Nawab A, Sharma N, Cottrill CL, Shapiro JI, Sodhi K.

Int J Med Sci. 2018 Oct 20;15(14):1591-1599. doi: 10.7150/ijms.27953. eCollection 2018. Review.

9.

Oxidized HDL, Adipokines, and Endothelial Dysfunction: A Potential Biomarker Profile for Cardiovascular Risk in Women with Obesity.

Peterson SJ, Shapiro JI, Thompson E, Singh S, Liu L, Weingarten JA, O'Hanlon K, Bialczak A, Bhesania SR, Abraham NG.

Obesity (Silver Spring). 2019 Jan;27(1):87-93. doi: 10.1002/oby.22354.

PMID:
30569635
10.

Developing a panel of biomarkers and miRNA in patients with myocardial infarction for early intervention strategies of heart failure in West Virginian population.

Lakhani HV, Khanal T, Gabi A, Yousef G, Alam MB, Sharma D, Aljoudi H, Puri N, Thompson E, Shapiro JI, Sodhi K.

PLoS One. 2018 Oct 24;13(10):e0205329. doi: 10.1371/journal.pone.0205329. eCollection 2018.

11.

Dietary Sodium Restriction Reduces Arterial Stiffness, Vascular TGF-β-Dependent Fibrosis and Marinobufagenin in Young Normotensive Rats.

Grigorova YN, Wei W, Petrashevskaya N, Zernetkina V, Juhasz O, Fenner R, Gilbert C, Lakatta EG, Shapiro JI, Bagrov AY, Fedorova OV.

Int J Mol Sci. 2018 Oct 15;19(10). pii: E3168. doi: 10.3390/ijms19103168.

12.

Uremic Toxins Activates Na/K-ATPase Oxidant Amplification Loop Causing Phenotypic Changes in Adipocytes in In Vitro Models.

Bartlett DE, Miller RB, Thiesfeldt S, Lakhani HV, Khanal T, D Pratt R, Cottrill CL, Klug RL, Adkins NS, Bown PC, Nease DB, Shapiro JI, Sodhi K.

Int J Mol Sci. 2018 Sep 10;19(9). pii: E2685. doi: 10.3390/ijms19092685.

13.

The Na/K-ATPase Signaling: From Specific Ligands to General Reactive Oxygen Species.

Pratt RD, Brickman CR, Cottrill CL, Shapiro JI, Liu J.

Int J Mol Sci. 2018 Sep 1;19(9). pii: E2600. doi: 10.3390/ijms19092600. Review.

14.

Quantum Modeling: A Bridge between the Pumping and Signaling Functions of Na/K-ATPase.

Wang W, Shapiro JI.

Int J Mol Sci. 2018 Aug 9;19(8). pii: E2347. doi: 10.3390/ijms19082347.

15.

The Role of Na/K-ATPase Signaling in Oxidative Stress Related to Aging: Implications in Obesity and Cardiovascular Disease.

Bartlett DE, Miller RB, Thiesfeldt S, Lakhani HV, Shapiro JI, Sodhi K.

Int J Mol Sci. 2018 Jul 23;19(7). pii: E2139. doi: 10.3390/ijms19072139. Review.

16.

The Na/K-ATPase Oxidant Amplification Loop Regulates Aging.

Sodhi K, Nichols A, Mallick A, Klug RL, Liu J, Wang X, Srikanthan K, Goguet-Rubio P, Nawab A, Pratt R, Lilly MN, Sanabria JR, Xie Z, Abraham NG, Shapiro JI.

Sci Rep. 2018 Jun 26;8(1):9721. doi: 10.1038/s41598-018-26768-9.

17.

PURE is not so pure when it comes to dietary sodium and cardiovascular events!

Khitan ZJ, Kheetan MM, Shapiro JI.

J Clin Hypertens (Greenwich). 2018 May;20(5):976-977. doi: 10.1111/jch.13267. Epub 2018 Mar 30. No abstract available.

18.

Principles of quantitative water and electrolyte replacement of losses from osmotic diuresis.

Roumelioti ME, Ing TS, Rondon-Berrios H, Glew RH, Khitan ZJ, Sun Y, Malhotra D, Raj DS, Agaba EI, Murata GH, Shapiro JI, Tzamaloukas AH.

Int Urol Nephrol. 2018 Jul;50(7):1263-1270. doi: 10.1007/s11255-018-1822-0. Epub 2018 Mar 6. Review.

PMID:
29511980
19.

Dietary potassium and cardiovascular profile. Results from the modification of diet in renal disease dataset.

Khitan ZJ, Shweihat YR, Tzamaloukas AH, Shapiro JI.

J Clin Hypertens (Greenwich). 2018 Mar;20(3):611-612. doi: 10.1111/jch.13207. Epub 2018 Feb 19. No abstract available.

20.

Stroke volume and proteinuria in obesity-related glomerulopathy: potential role in pathogenesis and choice of antihypertensive regimen.

Ogu I, Shweihat YR, Shapiro JI, Khitan ZJ.

J Clin Hypertens (Greenwich). 2018 Apr;20(4):819-820. doi: 10.1111/jch.13245. Epub 2018 Feb 15. No abstract available.

21.

Fluid balance concepts in medicine: Principles and practice.

Roumelioti ME, Glew RH, Khitan ZJ, Rondon-Berrios H, Argyropoulos CP, Malhotra D, Raj DS, Agaba EI, Rohrscheib M, Murata GH, Shapiro JI, Tzamaloukas AH.

World J Nephrol. 2018 Jan 6;7(1):1-28. doi: 10.5527/wjn.v7.i1.1. Review.

22.

Targeting Na/K-ATPase Signaling: A New Approach to Control Oxidative Stress.

Liu J, Lilly MN, Shapiro JI.

Curr Pharm Des. 2018;24(3):359-364. doi: 10.2174/1381612824666180110101052.

23.

Dihydropyridine calcium channel blockers in the elderly with diabetic nephropathy: Are they safe?

Khitan ZJ, Tzamaloukas AH, Brodsky S, Shapiro JI.

J Clin Hypertens (Greenwich). 2018 Jan;20(1):203-204. doi: 10.1111/jch.13158. Epub 2018 Jan 6. No abstract available.

24.

Na/K-ATPase/src complex mediates regulation of CD40 in renal parenchyma.

Xie JX, Zhang S, Cui X, Zhang J, Yu H, Khalaf FK, Malhotra D, Kennedy DJ, Shapiro JI, Tian J, Haller ST.

Nephrol Dial Transplant. 2018 Jul 1;33(7):1138-1149. doi: 10.1093/ndt/gfx334.

25.

Systematic review of nephrotoxicity of drugs of abuse, 2005-2016.

Mansoor K, Kheetan M, Shahnawaz S, Shapiro AP, Patton-Tackett E, Dial L, Rankin G, Santhanam P, Tzamaloukas AH, Nadasdy T, Shapiro JI, Khitan ZJ.

BMC Nephrol. 2017 Dec 29;18(1):379. doi: 10.1186/s12882-017-0794-0. Review.

26.

Investigating Molecular Connections of Non-alcoholic Fatty Liver Disease with Associated Pathological Conditions in West Virginia for Biomarker Analysis.

Sharma DL, Lakhani HV, Klug RL, Snoad B, El-Hamdani R, Shapiro JI, Sodhi K.

J Clin Cell Immunol. 2017 Oct;8(5). pii: 523. doi: 10.4172/2155-9899.1000523. Epub 2017 Sep 29.

27.

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy.

Wang X, Chaudhry MA, Nie Y, Xie Z, Shapiro JI, Liu J.

J Vis Exp. 2017 Nov 7;(129). doi: 10.3791/55825.

28.

Corrigendum: Attenuation of Na/K-ATPase Mediated Oxidant Amplification with pNaKtide Ameliorates Experimental Uremic Cardiomyopathy.

Liu J, Tian J, Chaudhry M, Maxwell K, Yan Y, Wang X, Shah PT, Khawaja AA, Martin R, Robinette TJ, El-Hamdani A, Dodrill MW, Sodhi K, Drummond CA, Haller ST, Kennedy DJ, Abraham NG, Xie Z, Shapiro JI.

Sci Rep. 2017 Oct 20;7:46893. doi: 10.1038/srep46893.

29.

Establishing the presence or absence of chronic kidney disease: Uses and limitations of formulas estimating the glomerular filtration rate.

Alaini A, Malhotra D, Rondon-Berrios H, Argyropoulos CP, Khitan ZJ, Raj DSC, Rohrscheib M, Shapiro JI, Tzamaloukas AH.

World J Methodol. 2017 Sep 26;7(3):73-92. doi: 10.5662/wjm.v7.i3.73. eCollection 2017 Sep 26. Review.

30.

Spin Trapping: A Review for the Study of Obesity Related Oxidative Stress and Na+/K+-ATPase.

Nawab A, Nichols A, Klug R, Shapiro JI, Sodhi K.

J Clin Cell Immunol. 2017 Jun;8(3). pii: 505. doi: 10.4172/2155-9899.1000505. Epub 2017 May 17.

31.

Association Between High-Density Lipoprotein Cholesterol and Hyponatremia: Is There Something Else Low?

Khitan ZJ, Shapiro JI.

Am J Med. 2017 Nov;130(11):e473-e474. doi: 10.1016/j.amjmed.2017.06.020. Epub 2017 Jul 17. No abstract available.

PMID:
28729080
32.

A management strategy that reduces NICU admissions and decreases charges from the front line of the neonatal abstinence syndrome epidemic.

Loudin S, Werthammer J, Prunty L, Murray S, Shapiro JI, Davies TH.

J Perinatol. 2017 Oct;37(10):1108-1111. doi: 10.1038/jp.2017.101. Epub 2017 Jul 6.

33.

Existence of a Strong Correlation of Biomarkers and miRNA in Females with Metabolic Syndrome and Obesity in a Population of West Virginia.

Goguet-Rubio P, Klug RL, Sharma DL, Srikanthan K, Puri N, Lakhani VH, Nichols A, O'Hanlon KM, Abraham NG, Shapiro JI, Sodhi K.

Int J Med Sci. 2017 Apr 19;14(6):543-553. doi: 10.7150/ijms.18988. eCollection 2017.

34.

EET intervention on Wnt1, NOV, and HO-1 signaling prevents obesity-induced cardiomyopathy in obese mice.

Cao J, Singh SP, McClung JA, Joseph G, Vanella L, Barbagallo I, Jiang H, Falck JR, Arad M, Shapiro JI, Abraham NG.

Am J Physiol Heart Circ Physiol. 2017 Aug 1;313(2):H368-H380. doi: 10.1152/ajpheart.00093.2017. Epub 2017 Jun 2.

35.

Association between dietary potassium, body mass index, and proteinuria in normotensive and hypertensive individuals: Results from the Modification of Diet in Renal Disease study baseline data.

Santhanam P, Shapiro JI, Khitan Z.

J Clin Hypertens (Greenwich). 2017 May;19(5):558-559. doi: 10.1111/jch.13000. Epub 2017 Mar 29. No abstract available.

36.

Sodium potassium adenosine triphosphatase (Na/K-ATPase) as a therapeutic target for uremic cardiomyopathy.

Wang X, Liu J, Drummond CA, Shapiro JI.

Expert Opin Ther Targets. 2017 May;21(5):531-541. doi: 10.1080/14728222.2017.1311864. Epub 2017 Apr 3. Review.

37.

Cigarette smoking and cardio-renal events in patients with atherosclerotic renal artery stenosis.

Drummond CA, Brewster PS, He W, Ren K, Xie Y, Tuttle KR, Haller ST, Jamerson K, Dworkin LD, Cutlip DE, Murphy TP, D'Agostino RB Sr, Henrich WL, Tian J, Shapiro JI, Cooper CJ.

PLoS One. 2017 Mar 17;12(3):e0173562. doi: 10.1371/journal.pone.0173562. eCollection 2017.

38.

pNaKtide Attenuates Steatohepatitis and Atherosclerosis by Blocking Na/K-ATPase/ROS Amplification in C57Bl6 and ApoE Knockout Mice Fed a Western Diet.

Sodhi K, Srikanthan K, Goguet-Rubio P, Nichols A, Mallick A, Nawab A, Martin R, Shah PT, Chaudhry M, Sigdel S, El-Hamdani M, Liu J, Xie Z, Abraham NG, Shapiro JI.

Sci Rep. 2017 Mar 15;7(1):193. doi: 10.1038/s41598-017-00306-5.

39.

Na/K-ATPase Signaling and Salt Sensitivity: The Role of Oxidative Stress.

Liu J, Yan Y, Nie Y, Shapiro JI.

Antioxidants (Basel). 2017 Mar 2;6(1). pii: E18. doi: 10.3390/antiox6010018. Review.

40.

Hypertonicity: Clinical entities, manifestations and treatment.

Rondon-Berrios H, Argyropoulos C, Ing TS, Raj DS, Malhotra D, Agaba EI, Rohrscheib M, Khitan ZJ, Murata GH, Shapiro JI, Tzamaloukas AH.

World J Nephrol. 2017 Jan 6;6(1):1-13. doi: 10.5527/wjn.v6.i1.1. Review.

41.

Cigarette smoking causes epigenetic changes associated with cardiorenal fibrosis.

Drummond CA, Crotty Alexander LE, Haller ST, Fan X, Xie JX, Kennedy DJ, Liu J, Yan Y, Hernandez DA, Mathew DP, Cooper CJ, Shapiro JI, Tian J.

Physiol Genomics. 2016 Dec 1;48(12):950-960. doi: 10.1152/physiolgenomics.00070.2016. Epub 2016 Oct 27.

42.

Attenuation of Na/K-ATPase Mediated Oxidant Amplification with pNaKtide Ameliorates Experimental Uremic Cardiomyopathy.

Liu J, Tian J, Chaudhry M, Maxwell K, Yan Y, Wang X, Shah PT, Khawaja AA, Martin R, Robinette TJ, El-Hamdani A, Dodrill MW, Sodhi K, Drummond CA, Haller ST, Kennedy DJ, Abraham NG, Xie Z, Shapiro JI.

Sci Rep. 2016 Oct 4;6:34592. doi: 10.1038/srep34592. Erratum in: Sci Rep. 2017 Oct 20;7:46893.

43.

Rapamycin Attenuates Cardiac Fibrosis in Experimental Uremic Cardiomyopathy by Reducing Marinobufagenin Levels and Inhibiting Downstream Pro-Fibrotic Signaling.

Haller ST, Yan Y, Drummond CA, Xie J, Tian J, Kennedy DJ, Shilova VY, Xie Z, Liu J, Cooper CJ, Malhotra D, Shapiro JI, Fedorova OV, Bagrov AY.

J Am Heart Assoc. 2016 Sep 30;5(10). pii: e004106.

44.

Targeted disruption of Cd40 in a genetically hypertensive rat model attenuates renal fibrosis and proteinuria, independent of blood pressure.

Haller ST, Kumarasamy S, Folt DA, Wuescher LM, Stepkowski S, Karamchandani M, Waghulde H, Mell B, Chaudhry M, Maxwell K, Upadhyaya S, Drummond CA, Tian J, Filipiak WE, Saunders TL, Shapiro JI, Joe B, Cooper CJ.

Kidney Int. 2017 Feb;91(2):365-374. doi: 10.1016/j.kint.2016.08.015. Epub 2016 Sep 28.

45.

Relationship of Albuminuria and Renal Artery Stent Outcomes: Results From the CORAL Randomized Clinical Trial (Cardiovascular Outcomes With Renal Artery Lesions).

Murphy TP, Cooper CJ, Pencina KM, D'Agostino R, Massaro J, Cutlip DE, Jamerson K, Matsumoto AH, Henrich W, Shapiro JI, Tuttle KR, Cohen DJ, Steffes M, Gao Q, Metzger DC, Abernethy WB, Textor SC, Briguglio J, Hirsch AT, Tobe S, Dworkin LD.

Hypertension. 2016 Nov;68(5):1145-1152. Epub 2016 Sep 19.

46.

Protein Carbonylation of an Amino Acid Residue of the Na/K-ATPase α1 Subunit Determines Na/K-ATPase Signaling and Sodium Transport in Renal Proximal Tubular Cells.

Yan Y, Shapiro AP, Mopidevi BR, Chaudhry MA, Maxwell K, Haller ST, Drummond CA, Kennedy DJ, Tian J, Malhotra D, Xie ZJ, Shapiro JI, Liu J.

J Am Heart Assoc. 2016 Sep 9;5(9). pii: e003675. doi: 10.1161/JAHA.116.003675.

47.

The Role of Na/K-ATPase Signaling in Oxidative Stress Related to Obesity and Cardiovascular Disease.

Srikanthan K, Shapiro JI, Sodhi K.

Molecules. 2016 Sep 3;21(9). pii: E1172. doi: 10.3390/molecules21091172. Review.

48.

Carbonylation Modification Regulates Na/K-ATPase Signaling and Salt Sensitivity: A Review and a Hypothesis.

Shah PT, Martin R, Yan Y, Shapiro JI, Liu J.

Front Physiol. 2016 Jun 28;7:256. doi: 10.3389/fphys.2016.00256. eCollection 2016. Review.

49.

Hypertonicity: Pathophysiologic Concept and Experimental Studies.

Argyropoulos C, Rondon-Berrios H, Raj DS, Malhotra D, Agaba EI, Rohrscheib M, Khitan Z, Murata GH, Shapiro JI, Tzamaloukas AH.

Cureus. 2016 May 2;8(5):e596. doi: 10.7759/cureus.596. Review.

50.

Effects of Stenting for Atherosclerotic Renal Artery Stenosis on eGFR and Predictors of Clinical Events in the CORAL Trial.

Tuttle KR, Dworkin LD, Henrich W, Greco BA, Steffes M, Tobe S, Shapiro JI, Jamerson K, Lyass A, Pencina K, Massaro JM, D'Agostino RB Sr, Cutlip DE, Murphy TP, Cooper CJ.

Clin J Am Soc Nephrol. 2016 Jul 7;11(7):1180-8. doi: 10.2215/CJN.10491015. Epub 2016 May 25.

Supplemental Content

Loading ...
Support Center